A detailed history of Federated Hermes, Inc. transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 4,823 shares of AADI stock, worth $14,469. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,823
Previous 4,294 12.32%
Holding current value
$14,469
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.32 - $2.06 $698 - $1,089
529 Added 12.32%
4,823 $9,000
Q2 2024

Aug 08, 2024

BUY
$1.46 - $2.31 $846 - $1,339
580 Added 15.62%
4,294 $6,000
Q1 2024

May 14, 2024

BUY
$1.59 - $2.44 $5,181 - $7,951
3,259 Added 716.26%
3,714 $8,000
Q4 2023

Jan 31, 2024

BUY
$1.97 - $5.41 $896 - $2,461
455 New
455 $0
Q1 2023

May 08, 2023

SELL
$6.85 - $13.0 $100,551 - $190,827
-14,679 Reduced 98.72%
191 $1,000
Q4 2022

Feb 13, 2023

BUY
$11.99 - $14.5 $178,291 - $215,615
14,870 New
14,870 $190,000

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $63.1M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.